Latest News

July 24, 2013
UCSF researchers are recommending six comprehensive measures to prevent the spread of hepatitis C for the estimated 31,000 young people who may be newly infected each year in the U.S. due to injection-drug use.
July 22, 2013
A research team led by scientists from the Ernest Gallo Clinic and Research Center at UCSF has identified circuitry in the brain that drives compulsive drinking in rats, and likely plays a similar role in humans.
April 03, 2013
By stimulating one part of the brain with laser light, researchers at the National Institutes of Health and the Ernest Gallo Clinic and Research Center at UCSF have shown that they can wipe away addictive behavior in rats – or conversely turn non-addicted rats into compulsive cocaine seekers.
February 19, 2013
A study by researchers at the Ernest Gallo Clinic and Research Center at UCSF identified a potential new approach for reducing problem drinking: a new family of drugs with the ability to manipulate DNA structure without changing it.
November 26, 2012
Decreasing the level of a key brain protein led to significantly less drinking and alcohol-seeking behavior in rats and mice that had been trained to drink, according to a study by researchers at the Ernest Gallo Clinic and Research Center at UCSF.
July 11, 2012
The UCSF-affiliated Ernest Gallo Clinic and Research Center has been selected to administer and manage a U.S. Army-funded research program intended to accelerate the discovery and development of new medications to treat alcohol and substance abuse in the context of post-traumatic stress and combat injury.
June 01, 2012
New UCSF research builds on a 1978 study called the “holiday heart syndrome,” establishing a stronger causal link between alcohol consumption and serious palpitations in patients with atrial fibrillation, the most common form of arrhythmia.
May 03, 2012
A popular smoking cessation medication has been under a cloud of suspicion ever since the Canadian Medical Association Journal published a study in July 2011 reporting “risk of serious adverse cardiovascular events associated with varenicline.” UCSF researchers, however, question the way the previous study was conducted, and their new analysis, scheduled to be published May 4 in BMJ, reaches a very different conclusion.
May 02, 2012
The smoking cessation drug varenicline significantly reduced alcohol consumption in a group of heavy-drinking smokers, in a study carried out by researchers at the Ernest Gallo Clinic and Research Center at the University of California, San Francisco.
April 18, 2012
Half of young adult tobacco smokers also have smoked marijuana in the last 30 days, according to a recent Facebook-based survey conducted by UCSF researchers, indicating a greater prevalence of marijuana and tobacco co-use among smokers age 18-25 than previously reported.

Pages